Whitney E Melroy-Greif1, Matthew A Simonson2, Robin P Corley3, Sharon M Lutz4, John E Hokanson5, Marissa A Ehringer3,6. 1. Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, CA. 2. Massachusetts Institute of Technology, Cambridge, MA. 3. Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO. 4. Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO. 5. Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO. 6. Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO.
Abstract
INTRODUCTION: Cigarette smoking is a physiologically harmful habit. Nicotinic acetylcholine receptors (nAChRs) are bound by nicotine and upregulated in response to chronic exposure to nicotine. It is known that upregulation of these receptors is not due to a change in mRNA of these genes, however, more precise details on the process are still uncertain, with several plausible hypotheses describing how nAChRs are upregulated. We have manually curated a set of genes believed to play a role in nicotine-induced nAChR upregulation. Here, we test the hypothesis that these genes are associated with and contribute risk for nicotine dependence (ND) and the number of cigarettes smoked per day (CPD). METHODS: Studies with genotypic data on European and African Americans (EAs and AAs, respectively) were collected and a gene-based test was run to test for an association between each gene and ND and CPD. RESULTS: Although several novel genes were associated with CPD and ND at P < 0.05 in EAs and AAs, these associations did not survive correction for multiple testing. Previous associations between CHRNA3, CHRNA5, CHRNB4 and CPD in EAs were replicated. CONCLUSIONS: Our hypothesis-driven approach avoided many of the limitations inherent in pathway analyses and provided nominal evidence for association between cholinergic-related genes and nicotine behaviors. IMPLICATIONS: We evaluated the evidence for association between a manually curated set of genes and nicotine behaviors in European and African Americans. Although no genes were associated after multiple testing correction, this study has several strengths: by manually curating a set of genes we circumvented the limitations inherent in many pathway analyses and tested several genes that had not yet been examined in a human genetic study; gene-based tests are a useful way to test for association with a set of genes; and these genes were collected based on literature review and conversations with experts, highlighting the importance of scientific collaboration.
INTRODUCTION: Cigarette smoking is a physiologically harmful habit. Nicotinic acetylcholine receptors (nAChRs) are bound by nicotine and upregulated in response to chronic exposure to nicotine. It is known that upregulation of these receptors is not due to a change in mRNA of these genes, however, more precise details on the process are still uncertain, with several plausible hypotheses describing how nAChRs are upregulated. We have manually curated a set of genes believed to play a role in nicotine-induced nAChR upregulation. Here, we test the hypothesis that these genes are associated with and contribute risk for nicotine dependence (ND) and the number of cigarettes smoked per day (CPD). METHODS: Studies with genotypic data on European and African Americans (EAs and AAs, respectively) were collected and a gene-based test was run to test for an association between each gene and ND and CPD. RESULTS: Although several novel genes were associated with CPD and ND at P < 0.05 in EAs and AAs, these associations did not survive correction for multiple testing. Previous associations between CHRNA3, CHRNA5, CHRNB4 and CPD in EAs were replicated. CONCLUSIONS: Our hypothesis-driven approach avoided many of the limitations inherent in pathway analyses and provided nominal evidence for association between cholinergic-related genes and nicotine behaviors. IMPLICATIONS: We evaluated the evidence for association between a manually curated set of genes and nicotine behaviors in European and African Americans. Although no genes were associated after multiple testing correction, this study has several strengths: by manually curating a set of genes we circumvented the limitations inherent in many pathway analyses and tested several genes that had not yet been examined in a human genetic study; gene-based tests are a useful way to test for association with a set of genes; and these genes were collected based on literature review and conversations with experts, highlighting the importance of scientific collaboration.
Authors: Jane E Sarginson; Joel D Killen; Laura C Lazzeroni; Stephen P Fortmann; Heather S Ryan; Alan F Schatzberg; Greer M Murphy Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2011-01-25 Impact factor: 3.568
Authors: Pingxing Xie; Henry R Kranzler; Michael Krauthammer; Kelly P Cosgrove; David Oslin; Raymond F Anton; Lindsay A Farrer; Marina R Picciotto; John H Krystal; Hongyu Zhao; Joel Gelernter Journal: Biol Psychiatry Date: 2011-06-17 Impact factor: 13.382
Authors: Nancy L Saccone; Robert C Culverhouse; Tae-Hwi Schwantes-An; Dale S Cannon; Xiangning Chen; Sven Cichon; Ina Giegling; Shizhong Han; Younghun Han; Kaisu Keskitalo-Vuokko; Xiangyang Kong; Maria Teresa Landi; Jennie Z Ma; Susan E Short; Sarah H Stephens; Victoria L Stevens; Lingwei Sun; Yufei Wang; Angela S Wenzlaff; Steven H Aggen; Naomi Breslau; Peter Broderick; Nilanjan Chatterjee; Jingchun Chen; Andrew C Heath; Markku Heliövaara; Nicole R Hoft; David J Hunter; Majken K Jensen; Nicholas G Martin; Grant W Montgomery; Tianhua Niu; Thomas J Payne; Leena Peltonen; Michele L Pergadia; John P Rice; Richard Sherva; Margaret R Spitz; Juzhong Sun; Jen C Wang; Robert B Weiss; William Wheeler; Stephanie H Witt; Bao-Zhu Yang; Neil E Caporaso; Marissa A Ehringer; Tim Eisen; Susan M Gapstur; Joel Gelernter; Richard Houlston; Jaakko Kaprio; Kenneth S Kendler; Peter Kraft; Mark F Leppert; Ming D Li; Pamela A F Madden; Markus M Nöthen; Sreekumar Pillai; Marcella Rietschel; Dan Rujescu; Ann Schwartz; Christopher I Amos; Laura J Bierut Journal: PLoS Genet Date: 2010-08-05 Impact factor: 5.917
Authors: S P David; A Hamidovic; G K Chen; A W Bergen; J Wessel; J L Kasberger; W M Brown; S Petruzella; E L Thacker; Y Kim; M A Nalls; G J Tranah; Y J Sung; C B Ambrosone; D Arnett; E V Bandera; D M Becker; L Becker; S I Berndt; L Bernstein; W J Blot; U Broeckel; S G Buxbaum; N Caporaso; G Casey; S J Chanock; S L Deming; W R Diver; C B Eaton; D S Evans; M K Evans; M Fornage; N Franceschini; T B Harris; B E Henderson; D G Hernandez; B Hitsman; J J Hu; S C Hunt; S A Ingles; E M John; R Kittles; S Kolb; L N Kolonel; L Le Marchand; Y Liu; K K Lohman; B McKnight; R C Millikan; A Murphy; C Neslund-Dudas; S Nyante; M Press; B M Psaty; D C Rao; S Redline; J L Rodriguez-Gil; B A Rybicki; L B Signorello; A B Singleton; J Smoller; B Snively; B Spring; J L Stanford; S S Strom; G E Swan; K D Taylor; M J Thun; A F Wilson; J S Witte; Y Yamamura; L R Yanek; K Yu; W Zheng; R G Ziegler; A B Zonderman; E Jorgenson; C A Haiman; H Furberg Journal: Transl Psychiatry Date: 2012-05-22 Impact factor: 6.222
Authors: Luke M Evans; Emma C Johnson; Whitney E Melroy-Greif; John K Hewitt; Charles A Hoeffer; Matthew C Keller; Laura M Saba; Jerry A Stitzel; Marissa A Ehringer Journal: Nicotine Tob Res Date: 2020-07-16 Impact factor: 4.244
Authors: Mauricio Arcos-Burgos; Jorge I Vélez; Ariel F Martinez; Marta Ribasés; Josep A Ramos-Quiroga; Cristina Sánchez-Mora; Vanesa Richarte; Carlos Roncero; Bru Cormand; Noelia Fernández-Castillo; Miguel Casas; Francisco Lopera; David A Pineda; Juan D Palacio; Johan E Acosta-López; Martha L Cervantes-Henriquez; Manuel G Sánchez-Rojas; Pedro J Puentes-Rozo; Brooke S G Molina; Margaret T Boden; Deeann Wallis; Brett Lidbury; Saul Newman; Simon Easteal; James Swanson; Hardip Patel; Nora Volkow; Maria T Acosta; Francisco X Castellanos; Jose de Leon; Claudio A Mastronardi; Maximilian Muenke Journal: Transl Psychiatry Date: 2019-01-29 Impact factor: 6.222